Adrenal Suppression not predicted by inhaled corticosteroids ( It is proved beyond doubt that asthma i...)

Adrenal Suppression not predicted by inhaled corticosteroids

It is proved beyond doubt that asthma is affected beneficially by long-term treatment with inhaled corticosteroids (ICS) in childhood//.

Although there is a lot of side affects that are associated with it. Which include adrenal suppression and growth deceleration; continue to be of concern to physicians that treat asthmatic children.

The main researchers were Kostas N. Priftis (Department of Allergology-Pulmonology, Penteli Children's Hospital, P. Penteli, Greece) and colleagues from Cyprus and Greece. They studied if impairment of growth of these children can predict adrenal function suppression.

To test the hypothesis low dose synacthen test was performed in 72 asthmatic children on long-term treatment (6-84 months) with low to moderate doses of inhaled budesonide. The parameters studied were changes in height standard deviation scores (HSDS) at the time of testing and height velocity SDS (HVSDS) in the preceding year were also calculated.

Adrenal suppression was demonstrated in 15 asthmatic children (20.8%) but this was only a biochemical finding. There was no correlation between adrenal response and dose or duration of treatment. However, a positive relation between HVSDS and duration of treatment was noted.

As a conclusion it is said that long-term treatment of asthmatic children with low to moderate doses of inhaled budesonide may result in mild adrenal suppression that can not be predicted by growth deceleration.

Durationg increase has a negative effect on the children.

Page: 1
Related medicine news :

1. Genetic Link to Adrenal Tumor Revealed
2. Adrenaline Associated With Adventurers Risk Taking
3. Stock of Adrenaline Runs Out, in New Zealand Hospitals
4. Targeting the Adrenal Gland Could Be Key Against Heart Failure
5. Transplant Cures Rats’ Type 2 Diabetes without Need for Immune Suppression Drug
6. Long-time Gastric Acid Suppression Does Not Increase The Risk Of Cancer
7. Suppression of Enzyme Delays a Type of Breast Cancer
8. Should Menstrual Suppression Be a Lifestyle Choice?
9. Epilepsy can be predicted
10. Effect of Osteosarcoma predicted by scans
11. Periodontal disease can be predicted by trends in obesity!

Post Your Comments:

(Date:12/5/2009)... advanced Technology Center helps companies develo...y available to the lab allows it to work in a vari... relating to cleaning parts, process development, ...s) December 5, 2009 -- Midbrook, Inc , a Jackson,...gy center laboratory that performs a wide variety ...

(Date:12/4/2009)...ent Trust Inc. (NYSE: CRE ) ("Care" or the "Com... has declared a dividend of $0.17 per share of com..., 2009 to common shareholders of record on Decembe... Care Investment Trust Inc. is a real estate inves...related real estate and commercial mortgage debt. ...

(Date:12/4/2009)...lthcare Trust of America, Inc. ("HTA"), a self-man...nounced the execution of a purchase and sale agree...rtfolio located in San Angelo, Texas, Corsicana, T...0,500,000. The closing of the acquisition is subj... ,, The approximately 92,500 square foot portfolio...

(Date:12/4/2009)...se to the U.S. Justice Department Drug Enforcement...methyltestosterone, and 19-nor-4,9(10)-androstadie...ed Substances Act (CSA), John Gay, executive direc...PA), the oldest and largest trade association rep...upplements and other natural products, issued the ...

(Date:12/4/2009)...re recruited annually to participate in clinical t... Protection (AHRP), and most will be compensated f...ns view payments to volunteers as compensation for...ial risks related to participating in the experime...very different view of clinical trial compensation...

Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2 Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3 Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2 Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2 Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2 Health News:Human guinea pigs wary of high-paying medical trials 2

[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification [0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share [0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana [0] Natural Products Association Issues Statement on DEA's Steroid Classification Action [0] Human guinea pigs wary of high-paying medical trials

...are unregulated and could be dangerous, agency say...- U.S. health officials warned Wednesday about so ... (BHRT) drugs, an increasing popular alternative t...t of them Internet-based, saying that claims touti...

...nts, needs from product design and development thr...AN FRANCISCO, Jan. 9 Hiemstra Product Development..., announced today that it has,received Food and Dr...edical devices in its 750 sq. ft., class 10,000,CE...

... 9 TeamStaff, Inc.,(Nasdaq: TSTF ) a national pr...ervices, today announced that on January 4, 2008, ...Nasdaq Stock Market ("Nasdaq"),indicating that Tea...aff informing it that for 30 consecutive business,...

...steroids, insulin don,t combat mortality , ...tudies on the treatment of septic shock question t...roids, intensive insulin therapy or with the synth...found no improvement in survival rates. , The seco...

...few weeks since you made that New Years resolution...ns to skip days maybe even weeks. , You know al... to the weight loss, which would obviously be nice...TV instead of going for a short jog is just too gr...

...n. 9 The 11th annual LSU,Health Care Services Div...led "Eliminating Disparities and Improving Access ..., 2008, at the Holiday Inn,Select, 4728 Constituti...e presenters will show how redesign and,improvemen...

FDA Warns Against Bio-Identical Hormone Therapy Hiemstra Approved to Manufacture Medical Devices in New CER TeamStaff Receives Nasdaq Determination Letter Standard Septic Shock Treatments Ineffective Exercising judgment: The psychology of fitness LSU Forum Examines Health-Care Disparities and Access to Care

(Date:12/4/2009)...Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ...leconference and webcast. Principal investigators...arfilzomib in relapsed and/or refractory multiple ...of Hematology (ASH) Annual Meeting. ,, The telecon...n Monday, December 7, 2009. The live webcast will...

(Date:12/4/2009)...4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefe...inst biological and chemical threats, announced to...s anthrax vaccine program showing that its lyophil...thrax vaccine is structurally stable and potent af...cluding 55 degrees C. The data were presented by ...

(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a biodefens...st biological and chemical threats, announced toda...y demonstrating the effectiveness of Valortim®...d White (NZW) rabbit. The data are being presente...Emergency Medical Countermeasures Enterprise (PHEM...

[0] Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference [0] PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop [0] PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop

...NGHAM, Ala., Oct. 12 BioCryst,Pharmaceuticals, In...itiated,enrollment of the pivotal trial of its lea...reatment of patients with cutaneous T-cell lymphom...prnh/20030414/BIOCRYSTLOGO ) The multinational t...ne,HCL treatment, will be conducted in accordance ...

...VILLE, Calif., Oct. 11 KineMed Inc., a,pathway-ba...ced today,presentation of data demonstrating the a...erve cells in the hippocampus, a part of the brain... of a partnered relationship in,indications discov...t in a,preclinical model. The findings were disclo...

Other Medicine Technology:BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL) 2 BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL) 3 BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL) 4 KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 2 KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 3

BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model

Lambert Rake Membrane Spatula

Olk Angled Retinal Spatula - 110 Degree

Castroviejo Cyclodialysis Spatula

Cleasby Iris Spatula

Medicine Products:

Lambert Rake Membrane Spatula Olk Angled Retinal Spatula - 110 Degree Castroviejo Cyclodialysis Spatula Cleasby Iris Spatula

( It is proved beyond doubt that asthma i...)Adrenal Suppression not predicted by inhaled corticosteroids,Health